Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

3.000

-0.090 (-2.91%)

May 30, 2025, 4:00 PM - Market closed

Eledon Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	180	246	44	31	63	233	Upgrade
Market Cap Growth	297.14%	465.07%	38.87%	-50.29%	-72.98%	3004.22%	Upgrade
Enterprise Value	56	168	-16	-34	-31	284	Upgrade
Last Close Price	3.00	4.12	1.80	2.28	4.41	15.40	Upgrade
PB Ratio	1.57	2.08	6.04	0.37	0.39	1.23	Upgrade
P/TBV Ratio	2.19	2.87	-	0.61	0.76	2.13	Upgrade
Debt / Equity Ratio	0.01	0.01	0.05	0.01	0.01	0.00	Upgrade
Quick Ratio	13.60	12.11	13.12	8.71	19.28	46.04	Upgrade
Current Ratio	13.91	12.42	14.41	9.19	20.07	46.57	Upgrade
Return on Equity (ROE)	-38.15%	-57.73%	-255.03%	-70.89%	-19.46%	-22.80%	Upgrade
Return on Assets (ROA)	-40.10%	-33.11%	-29.56%	-18.88%	-12.53%	-7.98%	Upgrade
Return on Capital (ROIC)	-96.11%	-69.64%	-58.09%	-19.91%	-12.96%	-8.28%	Upgrade
Earnings Yield	-10.60%	-14.70%	-267.55%	-280.45%	-54.69%	-9.77%	Upgrade
FCF Yield	-30.39%	-19.21%	-90.75%	-90.62%	-45.83%	-6.52%	Upgrade
Buyback Yield / Dilution	-111.34%	-97.18%	-72.34%	3.61%	-921.03%	-121.42%	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q